Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). (Q34310190)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). |
scientific article |
Statements
1 reference
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). (English)
1 reference
Hagop M Kantarjian
1 reference
Jorge Cortes
1 reference
Elias Jabbour
1 reference
Michele Baccarani
1 reference
Charles Chuah
1 reference
Concepción Boqué
1 reference
M Brigid Bradley-Garelik
1 reference
Carolina Pavlovsky
1 reference
Juan Luis Steegmann
1 reference
Neil P Shah
1 reference
Jirà Mayer
1 reference
Dong-Wook Kim
1 reference
Hesham Mohamed
1 reference
Mark Wildgust
1 reference
5 December 2013
1 reference
1 reference
1 reference
Identifiers
1 reference